| |
Non-sarcopenic (n = 1270)
|
Sarcopenic (n = 150)
|
p-value
|
|---|
|
BIS eGFR category
|
No sarcopenia (n = 1114)
|
Probable sarcopenia (n = 156)
|
Confirmed sarcopenia (n = 65)
|
Severe sarcopenia (n = 85)
|
|---|
|
≥90 (n = 9)
|
6 (66.7%)
|
3 (33.3%)
|
0.026
|
|
3 (33.3%)
|
3 (33.3%)
|
2 (22.2%)
|
1 (11.1%)
| |
|
60–89 (n = 538)
|
483 (89.8%)
|
55 (10.2%)
|
0.745
|
|
440 (81.8%)
|
43 (8.0%)
|
26 (4.8%)
|
29 (5.4%)
| |
|
45–59 (n = 542)
|
496 (91.5%)
|
46 (8.5%)
|
0.046
|
|
436 (80.4%)
|
60 (11.1%)
|
25 (4.6%)
|
21 (3.9%)
| |
|
30–44 (n = 259)
|
225 (86.9%)
|
34 (13.1%)
|
0.138
|
|
188 (72.6%)
|
37 (14.3%)
|
10 (3.9%)
|
24 (9.3%)
| |
|
15–29 (n = 72)
|
60 (83.3%)
|
12 (16.7%)
|
0.084
|
|
47 (65.3%)
|
13 (18.1%)
|
2 (2.8%)
|
10 (13.9%)
| |
|
≥60 (n = 1089)
|
985 (90.4%)
|
104 (9.6%)
|
0.024
|
|
879 (80.7%)
|
106 (9.7%)
|
53 (4.9%)
|
51 (4.7%)
|
|
< 60 (n = 331)
|
285 (86.1%)
|
46 (13.9%)
|
|
235 (71.0%)
|
50 (15.1%)
|
12 (3.6%)
|
34 (10.3%)
|
- BIS Berlin Initiative Study, eGFR Estimated glomerular filtration rate
